Sun Pharmaceutical Industries is currently trading at Rs. 668.50, up by 3.80 points or 0.57% from its previous closing of Rs. 664.70 on the BSE.
The scrip opened at Rs. 669.50 and has touched a high and low of Rs. 673.00 and Rs. 652.75 respectively. So far 102465 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 721.90 on 11-May-2021 and a 52 week low of Rs. 452.60 on 29-Oct-2020.
Last one week high and low of the scrip stood at Rs. 684.50 and Rs. 652.75 respectively. The current market cap of the company is Rs. 160023.65 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.29% and 12.23% respectively.
Sun Pharmaceutical Industries has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up. The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |